Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Iovance Biotherapeutics (IOVA) Shares Outstanding: 2010-2025

Historic Shares Outstanding for Iovance Biotherapeutics (IOVA) over the last 9 years, with Sep 2025 value amounting to $385.5 million.

  • Iovance Biotherapeutics' Shares Outstanding rose 26.54% to $385.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $385.5 million, marking a year-over-year increase of 26.54%. This contributed to the annual value of $305.3 million for FY2024, which is 19.18% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Shares Outstanding of $385.5 million as of Q3 2025, which was up 12.73% from $341.9 million recorded in Q2 2025.
  • Over the past 5 years, Iovance Biotherapeutics' Shares Outstanding peaked at $385.5 million during Q3 2025, and registered a low of $224.4 million during Q1 2023.
  • Over the past 3 years, Iovance Biotherapeutics' median Shares Outstanding value was $297.3 million (recorded in 2024), while the average stood at $291.8 million.
  • Data for Iovance Biotherapeutics' Shares Outstanding shows a peak YoY surged of 32.32% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Iovance Biotherapeutics' Shares Outstanding stood at $256.1 million in 2023, then increased by 19.18% to $305.3 million in 2024, then climbed by 26.54% to $385.5 million in 2025.
  • Its Shares Outstanding stands at $385.5 million for Q3 2025, versus $341.9 million for Q2 2025 and $333.9 million for Q1 2025.